Jean Hurteau
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, PARP inhibition in cancer therapy, Testicular diseases and treatments, BRCA gene mutations in cancer
Most-Cited Works
- → Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study(2014)582 cited
- → Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy(2006)329 cited
- Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.(1995)
- → Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group Study(1999)250 cited
- → Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer(2019)187 cited
- → A Prospective Controlled Trial of Early Postoperative Oral Intake Following Major Abdominal Gynecologic Surgery(1997)127 cited
- → DNA Methylation in Ovarian Cancer(2001)119 cited
- → Regulation of Invasion of Epithelial Ovarian Cancer by Transforming Growth Factor-β(2001)112 cited
- → Adjuvant Treatment for Early Ovarian Cancer: A Randomized Phase III Trial of Intraperitoneal 32P or Intravenous Cyclophosphamide and Cisplatin—A Gynecologic Oncology Group Study(2003)109 cited
- → FIGO Stage IIIC Endometrial Carcinoma with Metastases Confined to Pelvic Lymph Nodes: Analysis of Treatment Outcomes, Prognostic Variables, and Failure Patterns Following Adjuvant Radiation Therapy(1999)102 cited